Projected Price to Earnings: Surmodics Corp (SRDX)

The market value dynamics of Surmodics, Inc. (SRDX) demonstrate a current figure of 0.00. The business relies on automated sterile cleanrooms, where machine vision systems guarantee perfect catheter coating thickness. High profits are driven by patents for chemical compositions integrated into the products of global behemoths. Due to the uniqueness of its components, Surmodics, Inc. (SRDX) maintains strong pricing power and consistently generates licensing royalties.

surmodics.com - SRDX Market Cap to Future Earnings Ratio (period 07/04/2022 - 11/29/2025)

Metric breakdowns and analytics for Surmodics Inc. (SRDX)

- stock quotes and analyst forecast:

Stock Price Surmodics|SRDX - Average Forecast Price

- company stock exchange capitalization indicators:

Market Valuation Surmodics Inc|SRDX - Enterprise Value

- issuer book value statistics:

Accounting Value per Share Surmodics|SRDX - Total Net Assets|Market Capitalization to Book Value Ratio surmodics.com|SRDX - Company Total Asset Base

- company liabilities and liquidity data:

- financial results and valuation multiples details:

SRDX - Company Profit|Projected Future Earnings Surmodics, Inc.|SRDX - Business Payback Period|Forward P/E Multiple Surmodics Corp|SRDX - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Surmodics Inc|SRDX - Operating profit EBITDA|Earnings per share for the last twelve months Surmodics|SRDX - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months surmodics.com|SRDX - Earnings per share increase in current year|Earnings growth forecast for next year Surmodics, Inc.

Fundamental valuation:SRDX Surmodics

The forward P/E ratio assesses the market value of an asset relative to expected earnings per share. The forward P/E dynamics of Surmodics, Inc. (SRDX) allow for a real-time assessment of the market's revision of the company's fundamental value. This metric measures investors' willingness to pay a premium for future revenue growth. For Surmodics, Inc. (SRDX), this indicator reflects the value of its unique coating patents. A monopoly position in the B2B medtech segment makes such expectations justified.

Competitors of Surmodics, Inc.